NON-SMALL CELL LUNG CARCINOMA
Clinical trials for NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope drug studied for Tough-to-Treat lung cancer
Disease control CompletedThis study looked back at how well the oral drug lorlatinib worked for 73 Taiwanese patients with a specific genetic type of advanced lung cancer. All participants had already tried at least one other treatment that stopped working. The goal was to see how effective and safe lorl…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New immune drug trial challenges standard chemo for lung cancer
Disease control CompletedThis large, completed Phase 3 trial tested whether a new immunotherapy drug (cemiplimab) works better than standard platinum-based chemotherapy as the first treatment for patients with advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have high levels of a ma…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope: boosting immune system to fight lung cancer before surgery
Disease control CompletedThis study tested whether giving an immunotherapy drug called pembrolizumab before and after surgery could help the immune system fight early-stage lung cancer. Thirty-five patients with operable lung cancer received two doses before surgery and four doses after. Researchers want…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Neal Ready MD PhD • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Targeted drug tested for indian lung cancer patients with rare mutation
Disease control CompletedThis study tested the safety and effectiveness of the drug capmatinib for Indian adults with advanced non-small cell lung cancer (NSCLC) that has a specific genetic change called a MET exon 14 skipping mutation. About 50 patients took capmatinib pills twice daily for 24 weeks. Th…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Major trial tests powerful new combo in fight against advanced lung cancer
Disease control CompletedThis large, completed Phase 3 trial tested if adding a new drug (vibostolimab) to an existing immunotherapy (pembrolizumab) worked better than the standard single drug for people with a specific type of advanced lung cancer (PD-L1 positive NSCLC). Over 1,200 participants were ran…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Diabetes drug added to lung cancer treatment in groundbreaking trial
Disease control CompletedThis study tested whether adding the common diabetes medication metformin to standard chemotherapy and radiation could better control stage III non-small cell lung cancer. Researchers randomly assigned 170 patients with inoperable lung cancer to receive either the standard treatm…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Doctors watch and wait: study tracks lung cancer treatment timing
Knowledge-focused CompletedThis study observed how doctors treat advanced lung cancer patients who don't have symptoms and aren't candidates for curative treatments. Researchers followed 46 patients to see whether immediate radiation therapy or waiting until symptoms develop leads to better outcomes. The s…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:41 UTC
-
Blood test could replace invasive cancer tracking
Knowledge-focused CompletedThis study investigated whether a simple blood test could monitor lung cancer progression without needing repeated tumor biopsies. Researchers followed 200 lung cancer patients to see if genetic markers in their blood matched their tumor's genetic changes. The goal was to develop…
Matched conditions: NON-SMALL CELL LUNG CARCINOMA
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Mar 06, 2026 15:38 UTC